|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocm57560389 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
050203s2004 njua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d ZID
|d OCLCQ
|d IDEBK
|d OCLCQ
|d DG1
|d BAKER
|d OKU
|d MERUC
|d CCO
|d E7B
|d AU@
|d DKDLA
|d OCLCE
|d UAB
|d OCLCQ
|d CUV
|d OCLCQ
|d OCLCF
|d OCLCQ
|d NLGGC
|d OCLCQ
|d EBLCP
|d UKDOC
|d COO
|d OCLCQ
|d DEBBG
|d AZK
|d TOA
|d COCUF
|d DG1
|d CHVBK
|d CNNOR
|d MOR
|d LIP
|d PIFBR
|d ZCU
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d GWDNB
|d OCLCO
|d WY@
|d OCLCO
|d U3W
|d LUE
|d OCLCQ
|d BRL
|d STF
|d OCLCO
|d WRM
|d GILDS
|d OCLCO
|d ICG
|d NRAMU
|d MOQ
|d VT2
|d OCLCQ
|d OCLCO
|d WYU
|d OCLCO
|d OCLCA
|d A6Q
|d OCLCQ
|d DKC
|d CEF
|d OCLCQ
|d UX1
|d OCLCQ
|d HS0
|d UWK
|d ADU
|d OCLCQ
|d UKCRE
|d N$T
|d AJS
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|d SFB
|
016 |
7 |
|
|a 1063159962
|2 DE-101
|
019 |
|
|
|a 85820535
|a 224341630
|a 369514162
|a 475926347
|a 478394575
|a 559973360
|a 645929625
|a 647474500
|a 649926233
|a 655186672
|a 704545057
|a 722439445
|a 744642680
|a 850821083
|a 961541437
|a 962672240
|a 973990156
|a 974097370
|a 981387701
|a 981614136
|a 988500646
|a 991908098
|a 992026790
|a 992885017
|a 995774292
|a 1005638508
|a 1018049519
|a 1037452301
|a 1038697496
|a 1042317829
|a 1043033810
|a 1045527291
|a 1058081729
|a 1066612674
|a 1076283962
|a 1081090027
|a 1081286183
|a 1096454953
|a 1100543371
|a 1101717327
|a 1109087886
|a 1110384075
|a 1112889533
|a 1119003112
|a 1120991174
|a 1121022757
|a 1131945076
|a 1135961966
|a 1153456800
|a 1228559370
|
020 |
|
|
|a 0471686735
|q (electronic bk.)
|
020 |
|
|
|a 9780471686736
|q (electronic bk.)
|
020 |
|
|
|a 9780471686743
|q (electronic bk.)
|
020 |
|
|
|a 0471686743
|q (electronic bk.)
|
020 |
|
|
|a 1280272910
|
020 |
|
|
|a 9781280272912
|
020 |
|
|
|a 9786610272914
|
020 |
|
|
|a 6610272913
|
020 |
|
|
|a 0470237082
|
020 |
|
|
|a 9780470237083
|
020 |
|
|
|z 9780471214809
|q (print ed.)
|
020 |
|
|
|z 0471214809
|q (print ed.)
|
024 |
7 |
|
|a 10.1002/0471686743
|2 doi
|
029 |
1 |
|
|a AU@
|b 000026144662
|
029 |
1 |
|
|a AU@
|b 000026446660
|
029 |
1 |
|
|a AU@
|b 000042840882
|
029 |
1 |
|
|a AU@
|b 000054713109
|
029 |
1 |
|
|a CHBIS
|b 009829581
|
029 |
1 |
|
|a CHNEW
|b 000927952
|
029 |
1 |
|
|a CHVBK
|b 480087105
|
029 |
1 |
|
|a DEBBG
|b BV043385113
|
029 |
1 |
|
|a DEBBG
|b BV044079472
|
029 |
1 |
|
|a DEBSZ
|b 484920936
|
029 |
1 |
|
|a GBVCP
|b 881915491
|
029 |
1 |
|
|a GWDNB
|b 1063159962
|
029 |
1 |
|
|a HEBIS
|b 231484356
|
029 |
1 |
|
|a NZ1
|b 12033099
|
035 |
|
|
|a (OCoLC)57560389
|z (OCoLC)85820535
|z (OCoLC)224341630
|z (OCoLC)369514162
|z (OCoLC)475926347
|z (OCoLC)478394575
|z (OCoLC)559973360
|z (OCoLC)645929625
|z (OCoLC)647474500
|z (OCoLC)649926233
|z (OCoLC)655186672
|z (OCoLC)704545057
|z (OCoLC)722439445
|z (OCoLC)744642680
|z (OCoLC)850821083
|z (OCoLC)961541437
|z (OCoLC)962672240
|z (OCoLC)973990156
|z (OCoLC)974097370
|z (OCoLC)981387701
|z (OCoLC)981614136
|z (OCoLC)988500646
|z (OCoLC)991908098
|z (OCoLC)992026790
|z (OCoLC)992885017
|z (OCoLC)995774292
|z (OCoLC)1005638508
|z (OCoLC)1018049519
|z (OCoLC)1037452301
|z (OCoLC)1038697496
|z (OCoLC)1042317829
|z (OCoLC)1043033810
|z (OCoLC)1045527291
|z (OCoLC)1058081729
|z (OCoLC)1066612674
|z (OCoLC)1076283962
|z (OCoLC)1081090027
|z (OCoLC)1081286183
|z (OCoLC)1096454953
|z (OCoLC)1100543371
|z (OCoLC)1101717327
|z (OCoLC)1109087886
|z (OCoLC)1110384075
|z (OCoLC)1112889533
|z (OCoLC)1119003112
|z (OCoLC)1120991174
|z (OCoLC)1121022757
|z (OCoLC)1131945076
|z (OCoLC)1135961966
|z (OCoLC)1153456800
|z (OCoLC)1228559370
|
037 |
|
|
|n Title subscribed to via ProQuest Academic Complete
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RS403
|b .C667 2004
|
060 |
|
4 |
|a 2004 J-576
|
060 |
|
4 |
|a QV 744
|b C761 2004
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a TDCW
|2 bicssc
|
082 |
0 |
4 |
|a 615/.31
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Contemporary drug synthesis /
|c Jie Jack Li [and others].
|
260 |
|
|
|a Hoboken, N.J. :
|b Wiley-Interscience,
|c ©2004.
|
300 |
|
|
|a 1 online resource (xv, 221 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Antithrombotics : Ticlopidine (Ticlid) and Clopidogrel (Plavix) -- Anti-inflammatory cyclooxygenase-2 selective inhibitors : Celecoxib (Celebrex) and Rofecoxib (Vioxx) -- H+/K+ -ATPase inhibitors : Esomeprazole (Nexium) -- Protein-tyrosine kinase inhibitors : Imatnib (Gleevec) and Gefitinib (Iressa) -- Non-sedating antihistamines -- Cosmeceuticals : Istretinoin (Accutane), Tazarotene (Tazorac), Minoxidil (Rogaine), and Finasteride (Propecia) -- Antibacterials : Ciprofloxacin (Cipro) and Linezolid (Zyvox) -- Atypical antipsychotics -- Atovastatin calcium (Lipitor) -- Antidepressants -- Anti-obesity : Orlistat (Xenical) -- Triptans for migrane -- PDE 5 inhibitors for erectile dysfunction : Sildenafil (Viagra), Vardenafil (Levitra), and Tadalafil (Cialis) -- Antiasthmatics.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
520 |
|
|
|a An integrated and insightful look at successful drug synthesis in today's drug discovery market The pharmaceutical industry is unquestionably vibrant today, with drug synthesis making a vital contribution. Whether in the early developmental stages of identifying and optimizing a lead, or the latter stages of process development and cost-effective scale-up, the ability to design elegant and economical synthetic routes is often a major factor in the eventual viability and commercial success of a drug.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
|
2 |
|a Drug Design
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|x methods
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|
650 |
|
6 |
|a Chimie pharmaceutique.
|
650 |
|
6 |
|a Médicaments
|x Conception.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|
653 |
|
|
|a Organic Chemistry.
|
653 |
|
|
|a FACsci
|
653 |
|
|
|a ER
|a Internet
|a Book
|a Full text
|
655 |
|
0 |
|a Electronic books.
|
700 |
1 |
|
|a Li, Jie Jack.
|
758 |
|
|
|i has work:
|a Contemporary drug synthesis (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGbK9Tp4bXQwwfQG8Ftp6C
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Contemporary drug synthesis.
|d Hoboken, N.J. : Wiley-Interscience, ©2004
|z 0471214809
|w (DLC) 2004301281
|w (OCoLC)55705551
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=221303
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 12966
|
938 |
|
|
|a Baker & Taylor
|b BKTY
|c 105.00
|d 105.00
|i 0471686743
|n 0007317878
|s active
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL221303
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 125315
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2298818
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2943101
|
994 |
|
|
|a 92
|b IZTAP
|